| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $9.68M | $135.16M | $91.37M | $53.91M | $200.58M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $224.32M | $289.72M | $282.41M | $185.46M | $128.60M |
| R&D | $134.85M | $222.52M | $220.57M | $135.56M | $82.28M |
| SG&A | $59.39M | $67.20M | $61.84M | $49.90M | $46.32M |
| Operating Income | -$214.64M | -$154.56M | -$191.04M | -$131.56M | $71.97M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $43.26M | -$6.62M | -$13.45M | -$8.66M | $4.95M |
| Net Income | -$244.09M | -$122.31M | -$147.03M | -$116.95M | $66.97M |
| EPS (basic) | -4.5300 | -2.2700 | -2.7600 | -2.4700 | 1.5100 |
| EPS (diluted) | -4.5300 | -2.2700 | -2.7600 | -2.4700 | 1.3800 |
| Shares (diluted) | $53.83M | $53.77M | $53.22M | $47.37M | $48.46M |